BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 22828861)

  • 21. Screening Mammography Program of British Columbia: pattern of use and health care system costs.
    Olivotto IA; Kan L; Mates D; King S
    CMAJ; 1999 Feb; 160(3):337-41. PubMed ID: 10065075
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Costs of different follow-up strategies in early breast cancer: a review of the literature.
    van Hezewijk M; van den Akker ME; van de Velde CJ; Scholten AN; Hille ET
    Breast; 2012 Dec; 21(6):693-700. PubMed ID: 23084960
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Attributable cost of obesity in breast surgery: a matched cohort analysis.
    Sun SX; Greenleaf EK; Hollenbeak CS; Leung AM
    Am J Surg; 2015 Oct; 210(4):668-77.e1. PubMed ID: 26212389
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A detailed report of the resource use and costs associated with implementation of a short stay programme for breast cancer surgery.
    Ament SM; de Kok M; van de Velde CJ; Roukema JA; Bell TV; van der Ent FW; van der Weijden T; von Meyenfeldt MF; Dirksen CD
    Implement Sci; 2015 May; 10():78. PubMed ID: 26013765
    [TBL] [Abstract][Full Text] [Related]  

  • 25. '23 h Model' for breast surgery: an early experience.
    Hainsworth AJ; Lobo CR; Williams P; Case C; Surridge F; Sharma AK; Banerjee D
    Breast; 2013 Oct; 22(5):898-901. PubMed ID: 23664255
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cost-effective preoperative evaluation, operative treatment, and postoperative follow-up in the breast cancer patient.
    Cady B
    Surg Clin North Am; 1996 Feb; 76(1):25-34. PubMed ID: 8629200
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sustainability of healthcare innovations (SUSHI): long term effects of two implemented surgical care programmes (protocol).
    Ament SM; Gillissen F; Maessen JM; Dirksen CD; van der Weijden T; von Meyenfeldt MF
    BMC Health Serv Res; 2012 Nov; 12():423. PubMed ID: 23174024
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cost of care in a randomised trial of early hospital discharge after surgery for breast cancer.
    Bonnema J; van Wersch AM; van Geel AN; Pruyn JF; Schmitz PI; Uyl-de Groot CA; Wiggers T
    Eur J Cancer; 1998 Dec; 34(13):2015-20. PubMed ID: 10070303
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Underuse of long-term routine hospital follow-up care in patients with a history of breast cancer?
    Lu W; Jansen L; Schaapveld M; Baas PC; Wiggers T; De Bock GH
    BMC Cancer; 2011 Jun; 11():279. PubMed ID: 21708039
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Minimizing length of hospital stay for patients undergoing unilateral mastectomy: A subtle balance between costs and quality of care.
    Olsha O; Ashkenazi I
    Eur J Surg Oncol; 2012 Jan; 38(1):4-5. PubMed ID: 22019152
    [No Abstract]   [Full Text] [Related]  

  • 31. Postoperative follow-up of patients with early breast cancer. Patterns of care among clinical oncologists and a review of the literature.
    Loomer L; Brockschmidt JK; Muss HB; Saylor G
    Cancer; 1991 Jan; 67(1):55-60. PubMed ID: 1985723
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cost of breast preservation surgery for cancer in the RSA.
    du Toit DF
    S Afr Med J; 1992 Sep; 82(3):209. PubMed ID: 1519149
    [No Abstract]   [Full Text] [Related]  

  • 33. The Skinner Lecture: a cost-benefit analysis of postoperative radiotherapy in the treatment of early breast cancer.
    Baum M
    Clin Oncol (R Coll Radiol); 1991 Jul; 3(4):223-9. PubMed ID: 1931764
    [No Abstract]   [Full Text] [Related]  

  • 34. Costs of lumpectomy vs mastectomy.
    Perez CA
    Arch Surg; 1987 Jun; 122(6):736. PubMed ID: 3579592
    [No Abstract]   [Full Text] [Related]  

  • 35. Routine follow up of breast cancer in primary care. Follow up by non-specialists should not be encouraged.
    Rainsbury D
    BMJ; 1996 Dec; 313(7071):1547. PubMed ID: 8978237
    [No Abstract]   [Full Text] [Related]  

  • 36. Impact of Hospital Volume on Breast Cancer Outcome: A Population Based Study in the Netherlands.
    Siesling S; Tjan-Heijnen V; de Roos M; Snel Y; van Dalen T; Wouters M; Struikmans H; van der Hoeven K; Maduro J; Visser O
    Value Health; 2014 Nov; 17(7):A620. PubMed ID: 27202179
    [No Abstract]   [Full Text] [Related]  

  • 37. Corrigendum to "A modelling study to evaluate the costs and effects of lowering the starting age of population breast cancer screening" [Maturitas 109 (2018) 81-88].
    Koleva-Kolarova RG; Daszczuk AM; de Jonge C; Abu Hantash MK; Zhan ZZ; Postema EJ; Feenstra TL; Pijnappel RM; Greuter MJW; de Bock GH
    Maturitas; 2018 Aug; 114():73. PubMed ID: 29779854
    [No Abstract]   [Full Text] [Related]  

  • 38. Simplified breast care.
    HOFFERT F
    Am J Nurs; 1948 Jun; 48(6):372. PubMed ID: 18857829
    [No Abstract]   [Full Text] [Related]  

  • 39. Personalized surveillance and aftercare for non-metastasized breast cancer: the NABOR study protocol of a multiple interrupted time series design.
    Klaassen-Dekker A; Drossaert CHC; Van Maaren MC; Van Leeuwen-Stok AE; Retel VP; Korevaar JC; Siesling S;
    BMC Cancer; 2023 Nov; 23(1):1112. PubMed ID: 37964214
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long-term effects of the interruption of the Dutch breast cancer screening program due to COVID-19: A modelling study.
    Poelhekken K; Greuter MJW; de Munck L; Siesling S; Brokken FB; de Bock GH
    Prev Med; 2023 Jan; 166():107376. PubMed ID: 36493865
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.